Stay updated on Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Sign up to get notified when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer updates include adding an HHS Vulnerability Disclosure link and updating the Revision from v3.3.1 to v3.3.2; these changes do not modify trial data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-01T11:47:55.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a new revision entry 'Revision: v3.3.1' to the history and removed the 'HHS Vulnerability Disclosure' item; the previous 'Revision: v3.2.0' entry remains in the history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-24T12:17:25.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The notice about government funding and NIH operating status in the page footer/banner was removed. This appears to be a cosmetic update with no impact on the study record or its data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T06:21:21.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new version entry was added to the Record History for NCT04878432, showing an updated Study Status. This reflects a recent change in the trial's status recorded by ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2025-11-03T01:05:12.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Updates date-related references: adds 2025-10-16 and a '23 2025-10-08 Study Status References' entry, and removes 2025-07-31.
    Difference
    1%
    Check dated 2025-10-19T16:21:07.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Significant: new government funding and operating-status notice plus a version upgrade to v3.2.0. Removed: old version tag v3.1.0.
    Difference
    11%
    Check dated 2025-10-05T09:08:31.000Z thumbnail image

Stay in the know with updates to Sabatolimab in HMA for Higher Risk MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sabatolimab in HMA for Higher Risk MDS Clinical Trial page.